The incidence and pathophysiology of neurological symptoms in COVID-19

Abstract

The central nervous system seems to be quite vulnerable to SARS-CoV-2, leading to a variety of alteration pathways, high incidence and variability of the neurological symptoms of COVID-19. The COVID-19 symptoms, possibly associated with alteration to the central nervous system, include hyperthermia, shortness of breath, fatigue, headache, dizziness, dysphonia, dysphagia, hyposmia and anosmia, hypogeusia and ageusia, impairment of consciousness. The impairment of olfaction and gustation are the most common symptoms of the nervous system alteration (98% and 70%, respectively), which is most likely a consequence of the alteration of the receptors. Presumably the pathogenesis of dysphonia and dysphagia may involve neurodegenerative mechanisms or may be associated with a predominantly demyelinating alteration of the caudal cranial nerves. Pathomorphological findings in the brain of the COVID-19 patients include diffuse hypoxic and focal ischemic injuries of various sizes up to ischemic infarctions (in thrombosis of large arteries); microangiopathy; vasculitis; diapedetic and confluent hemorrhages with possible progression to hemorrhagic infarctions and rarely intracerebral hematomas. Acute cerebrovascular accident worsens the course of COVID-19 and can worsen the clinical outcome, taking into account the mechanisms of the central nervous system alteration in highly contagious coronavirus infections (SARS-CoV, MERS, SARS-CoV-2), including embolism, hypoxia, neurodegeneration, systemic inflammatory response and immune-mediated alteartion to the nervous tissue. A fairly rare complication of coronavirus infection, however, acute myelitis requires attention due to the severity of neurological disorders. The literature data show high incidence and polymorphism of the symptoms of the central nervous system alteration, as well as the important role of the cerebrovascular and neurodegenerative pathogenesis of brain alteration in COVID-19, which is taken into account in examining and treating the patients with new coronavirus infection. (1 figure, bibliography: 61 refs)

Keywords

central hyperthermia / central nervous system / hypoxia / neurodegeneration / neurological symptoms / COVID-19 / SARS-CoV-2

References

[1] Chen X, Laurent S, Onur OA, et al. A systematic review of neurological symptoms and complications of COVID-19. J Neurol. 2021;268(2):392–402. DOI: 10.1007/s00415-020-10067-3

[2] Chen X., Laurent S., Onur O.A., et al. A systematic review of neurological symptoms and complications of COVID-19 // J. Neurol. 2021. Vol. 268, No. 2. P. 392–402. DOI: 10.1007/s00415-020-10067-3

[3] Mao L, Jin H, Wang M, et al. Neurologic Manifestations of Hospita lized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. 2020;77(6):683–690. DOI: 10.1001/jamaneurol.2020.1127

[4] Mao L., Jin H., Wang M., et al. Neurologic Manifestations of Hospitalized Patients with Coronavirus Disease 2019 in Wuhan, China // JAMA Neurol. 2020. Vol. 77, No. 6. P. 683–690. DOI: 10.1001/jamaneurol.2020.1127

[5] Yan CH, Faraji F, Prajapati DP, et al. Self-reported olfactory loss associates with outpatient clinical course in COVID-19. International Forum of Allergy & Rhinology. 2020;10(7):821–831. DOI: 10.1002/alr.22592

[6] Yan C.H., Faraji F., Prajapati D.P., et al. Self-reported olfactory loss associates with outpatient clinical course in COVID-19 // International Forum of Allergy & Rhinology. 2020. Vol. 10, No. 7. P. 821–831. DOI: 10.1002/alr.22592

[7] Yan CH, Faraji F, Prajapati DP, et al. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms. International Forum of Allergy & Rhinology. 2020;10(7):806–813. DOI: 10.1002/alr.22579

[8] Yan C.H., Faraji F., Prajapati D.P., et al. Association of chemosensory dysfunction and COVID-19 in patients presenting with influenza-like symptoms // International Forum of Allergy & Rhinology. 2020. Vol. 10, No. 7. P. 806–813. DOI: 10.1002/alr.22579

[9] Lechien JR, Chiesa-Estomba CM, De Siati DR, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020;277(8):2251–2261. DOI: 10.1007/s00405-020-05965-1

[10] Lechien J.R., Chiesa-Estomba C.M., De Siati D.R., et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study // Eur. Arch. Otorhinolaryngol. 2020 Vol. 277, No. 8. P. 2251–2261. DOI: 10.1007/s00405-020-05965-1

[11] Santos REA, da Silva MG, do Monte Silva MCB, et al. Onset and duration of symptoms of loss of smell/taste in patients with COVID-19: A systematic review. Am J Otolaryngol. 2021;42(2):102889. DOI: 10.1016/j.amjoto.2020.102889

[12] Santos R.E.A., da Silva M.G., do Monte Silva M.C.B., et al. Onset and duration of symptoms of loss of smell/taste in patients with COVID-19: A systematic review // Am. J. Otolaryngol. 2021. Vol. 42, No. 2. P. 102889. DOI: 10.1016/j.amjoto.2020.102889

[13] Beltrán-Corbellini Á, Chico-García JL, Martínez-Poles J, et al. Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicentre polymerase chain reaction based case–control study. European Journal of Neurology. 2020;27(9):1738–1741. DOI: 10.1111/ene.14273

[14] Beltrán-Corbellini Á., Chico-García J.L., Martínez-Poles J., et al. Acute-onset smell and taste disorders in the context of COVID-19: a pilot multicentre polymerase chain reaction based case–control study // European Journal of Neurology. 2020. Vol. 27, No. 9. P. 1738–1741. DOI: 10.1111/ene.14273

[15] Lechien JR, Chiesa-Estomba CM, Place S, et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019. Journal of Internal Medicine. 2020;288(3):335–344. DOI: 10.1111/joim.13089

[16] Lechien J.R., Chiesa-Estomba C.M., Place S., et al. Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019 // Journal of Internal Medicine. 2020. Vol. 288, No. 3. P. 335–344. DOI: 10.1111/joim.13089

[17] Collantes MEV, Espiritu AI, Sy MCC, Anlacan VMM, Jamora RDG. Neurological Manifestations in COVID-19 Infection: A Systematic Review and Meta-Analysis. Can J Neurol Sci. 2021;48(1):66–76. DOI: 10.1017/cjn.2020.146

[18] Collantes M.E.V., Espiritu A.I., Sy M.C.C., Anlacan V.M.M., Jamora R.D.G. Neurological Manifestations in COVID-19 Infection: A Systematic Review and Meta-Analysis // Can. J. Neurol. Sci. 2021. Vol. 48, No. 1. P. 66–76. DOI: 10.1017/cjn.2020.146

[19] Cagnazzo F, Arquizan C, Derraz I, et al. Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literature. J Neurol. 2021;268(8):2656–2665. DOI: 10.1007/s00415-020-10285-9

[20] Cagnazzo F., Arquizan C., Derraz I., et al. Neurological manifestations of patients infected with the SARS-CoV-2: a systematic review of the literature // J. Neurol. 2021. Vol. 268, No. 8. P. 2656–2665. DOI: 10.1007/s00415-020-10285-9

[21] Kim GU, Kim MJ, Ra SH, et al. Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19. Clin Microbiol Infect. 2020;26(7):948.e1–948.e3. DOI: 10.1016/j.cmi.2020.04.040

[22] Kim G.U., Kim M.J., Ra S.H., et al. Clinical characteristics of asymptomatic and symptomatic patients with mild COVID-19 // Clin. Microbiol. Infect. 2020. Vol. 26, No. 7. P. 948.e1–948.e3. DOI: 10.1016/j.cmi.2020.04.040

[23] Soltani S, Tabibzadeh A, Zakeri A, et al. COVID-19 associated central nervous system manifestations, mental and neurological symptoms: a systematic review and meta-analysis. Rev Neurosci. 2021;32(3):351–361. DOI: 10.1515/revneuro-2020-0108

[24] Soltani S., Tabibzadeh A., Zakeri A., et al. COVID-19 associated central nervous system manifestations, mental and neurological symptoms: a systematic review and meta-analysis // Rev. Neurosci. 2021. Vol. 32, No. 3. P. 351–361. DOI: 10.1515/revneuro-2020-0108

[25] Garg S. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 – COVID-NET, 14 States, March 1–30, 2020. Weekly. 2020;69(15):458–464. DOI: 10.15585/mmwr.mm6915e3

[26] Garg S., Kim L., Whitaker M., et al. Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 – COVID-NET, 14 States, March 1–30, 2020 // Weekly. 2020. Vol. 69, No. 15. P. 458–464. DOI: 10.15585/mmwr.mm6915e3

[27] Li X, Xu S, Yu M, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110–118. DOI: 10.1016/j.jaci.2020.04.006

[28] Li X., Xu S., Yu M., et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan // J. Allergy. Clin. Immunol. 2020. Vol. 146, No. 1. P. 110–118. DOI: 10.1016/j.jaci.2020.04.006

[29] Godaert L, Proye E, Demoustier-Tampere D, et al. Clinical characteristics of older patients: The experience of a geriatric short-stay unit dedicated to patients with COVID-19 in France. J Infect. 2020;81(1): e93–e94. DOI: 10.1016/j.jinf.2020.04.009

[30] Godaert L., Proye E., Demoustier-Tampere D., et al. Clinical characteristics of older patients: The experience of a geriatric short-stay unit dedicated to patients with COVID-19 in France // J. Infect. 2020. Vol. 81, No. 1. P. e93–e94. DOI: 10.1016/j.jinf.2020.04.009

[31] Helms J, Kremer S, Merdji H, et al. Neurologic Features in Severe SARS-CoV-2 Infection. New England Journal of Medicine. 2020;382(23):2268–2270. DOI: 10.1056/NEJMc2008597

[32] Helms J., Kremer S., Merdji H., et al. Neurologic Features in Severe SARS-CoV-2 Infection // New England Journal of Medicine. 2020. Vol. 382, No. 23. P. 2268–2270. DOI: 10.1056/NEJMc2008597

[33] Li K, Wohlford-Lenane C, Perlman S, et al. Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4. J Infect Dis. 2016;213(5):712–722. DOI: 10.1093/infdis/jiv499

[34] Li K., Wohlford-Lenane C., Perlman S., et al. Middle East Respiratory Syndrome Coronavirus Causes Multiple Organ Damage and Lethal Disease in Mice Transgenic for Human Dipeptidyl Peptidase 4 // J. Infect. Dis. 2016. Vol. 213, No. 5. P. 712–722. DOI: 10.1093/infdis/jiv499

[35] Netland J, Meyerholz DK, Moore S, et al. Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2. Journal of Virology. 2008;82(15):7264–7275. DOI: 10.1128/JVI.00737-08

[36] Netland J., Meyerholz D.K., Moore S., et al. Severe Acute Respiratory Syndrome Coronavirus Infection Causes Neuronal Death in the Absence of Encephalitis in Mice Transgenic for Human ACE2 // Journal of Virology. 2008. Vol. 82, No. 15. P. 7264–7275. DOI: 10.1128/JVI.00737-08

[37] Fazzini E, Fleming J, Fahn S. Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson’s disease. Mov Disord. 1992;7(2):153–158. DOI: 10.1002/mds.870070210

[38] Fazzini E., Fleming J., Fahn S. Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson’s disease // Mov. Disord. 1992. Vol. 7, No. 2. P. 153–158. DOI: 10.1002/mds.870070210

[39] Dessau RB, Lisby G, Frederiksen JL. Coronaviruses in brain tissue from patients with multiple sclerosis. Acta Neuropathol. 2001;101(6):601–604. DOI: 10.1007/s004010000331

[40] Dessau R.B., Lisby G., Frederiksen J.L. Coronaviruses in brain tissue from patients with multiple sclerosis // Acta Neuropathol. 2001. Vol. 101, No. 6. P. 601–604. DOI: 10.1007/s004010000331

[41] Liu K, Fang YY, Deng Y, et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Pro vince. Chinese Medical Journal. 2020;133(9):1025–1031. DOI: 10.1097/CM9.0000000000000744

[42] Liu K., Fang Y.Y., Deng Y., et al. Clinical characteristics of novel coronavirus cases in tertiary hospitals in Hubei Province // Chinese Medical Journal. 2020. Vol. 133, No. 9. P. 1025–1031. DOI: 10.1097/CM9.0000000000000744

[43] Xu XW, Wu X, Jiang XG, et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series. BMJ. 2020;368:606. DOI: 10.1136/bmj.m606

[44] Xu X.W., Wu X., Jiang X.G., et al. Clinical findings in a group of patients infected with the 2019 novel coronavirus (SARS-Cov-2) outside of Wuhan, China: retrospective case series // BMJ. 2020. No. 368. P. 606. DOI: 10.1136/bmj.m606

[45] Liu M, He P, Liu HG, et al. Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia. Zhonghua Jie He He Hu Xi Za Zhi. 2020;43(0): E016. DOI: 10.3760/cma.j.issn.1001-0939.2020.0016

[46] Liu M., He P., Liu H.G., et al. Clinical characteristics of 30 medical workers infected with new coronavirus pneumonia // Zhonghua Jie He He Hu Xi Za Zhi. 2020. Vol. 43. P. E016. DOI: 10.3760/cma.j.issn.1001-0939.2020.0016

[47] Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507–513. DOI: 10.1016/S0140-6736(20)30211-7

[48] Chen N., Zhou M., Dong X., et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study // Lancet. 2020. Vol. 395, No. 10223. P. 507–513. DOI: 10.1016/S0140-6736(20)30211-7

[49] Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497–506. DOI: 10.1016/S0140-6736(20)30183-5

[50] Huang C., Wang Y., Li X., et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China // Lancet. 2020. Vol. 395, No. 10223. P. 497–506. DOI: 10.1016/S0140-6736(20)30183-5

[51] Jin X, Lian JS, Hu JH, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut. 2020;69(6):1002–1009. DOI: 10.1136/gutjnl-2020-320926

[52] Jin X., Lian J.S., Hu J.H., et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms // Gut. 2020. Vol. 69, No. 6. P. 1002–1009. DOI: 10.1136/gutjnl-2020-320926

[53] Zhang X, Cai H, Hu J, et al. Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings. International Journal of Infectious Diseases. 2020;94:81–87. DOI: 10.1016/j.ijid.2020.03.040

[54] Zhang X., Cai H., Hu J., et al. Epidemiological, clinical characteristics of cases of SARS-CoV-2 infection with abnormal imaging findings // International Journal of Infectious Diseases. 2020. No. 94. P. 81–87. DOI: 10.1016/j.ijid.2020.03.040

[55] Duanmu Y, Brown IP, Gibb WR, et al. Characteristics of Emergency Department Patients With COVID-19 at a Single Site in Northern California: Clinical Observations and Public Health Implications. Acad Emerg Med. 2020;27(6):505–509. DOI: 10.1111/acem.14003

[56] Duanmu Y., Brown I.P., Gibb W.R., et al. Characteristics of Emergency Department Patients With COVID-19 at a Single Site in Northern California: Clinical Observations and Public Health Implications // Acad. Emerg. Med. 2020. Vol. 27, No. 6. P. 505–509. DOI: 10.1111/acem.14003

[57] Meng Y, Wu P, Lu W, et al. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients. PLoS Pathog. 2020;16(4): e1008520. DOI: 10.1371/journal.ppat.1008520

[58] Meng Y., Wu P., Lu W., et al. Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients // PLoS Pathog. 2020. Vol. 16, No. 4. P. e1008520. DOI: 10.1371/journal.ppat.1008520

[59] Chen Q, Zheng Z, Zhang C, et al. Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China. Infection. 2020;48(4):543–551. DOI: 10.1007/s15010-020-01432-5

[60] Chen Q., Zheng Z., Zhang C., et al. Clinical characteristics of 145 patients with corona virus disease 2019 (COVID-19) in Taizhou, Zhejiang, China // Infection. 2020. Vol. 48, No. 4. P. 543–551. DOI: 10.1007/s15010-020-01432-5

[61] Kujawski SA, Wong KK, Collins JP, et al. Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States. Nature Medicine. 2020;26(6): 861–868. DOI: 10.1038/s41591-020-0877-5

[62] Kujawski S.A., Wong K.K., Collins J.P., et al. Clinical and virologic characteristics of the first 12 patients with coronavirus disease 2019 (COVID-19) in the United States // Nature Medicine. 2020. Vol. 26, No. 6. P. 861–868. DOI: 10.1038/s41591-020-0877-5

[63] Zheng S, Fan J, Yu F, et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study. BMJ. 2020;369:1443. DOI: 10.1136/bmj.m1443

[64] Zheng S., Fan J., Yu F., et al. Viral load dynamics and disease severity in patients infected with SARS-CoV-2 in Zhejiang province, China, January-March 2020: retrospective cohort study // BMJ. 2020. No. 369. P. 1443. DOI: 10.1136/bmj.m1443

[65] Zhou Y, Han T, Chen J, et al. Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19. Clin Transl Sci. 2020;13(6):1077–1086. DOI: 10.1111/cts.12805

[66] Zhou Y., Han T., Chen J., et al. Clinical and Autoimmune Characteristics of Severe and Critical Cases of COVID-19 // Clin. Transl. Sci. 2020. Vol. 13, No. 6. P. 1077–1086. DOI: 10.1111/cts.12805

[67] Jie B, Liu X, Suo H, et al. Clinical and Dynamic Computed Tomography Features of 24 Patients with Coronavirus Disease 2019. Can Assoc Radiol J. 2021;72(2):279–284. DOI: 10.1177/0846537120918834

[68] Jie B., Liu X., Suo H., et al. Clinical and Dynamic Computed Tomography Features of 24 Patients with Coronavirus Disease 2019 // Can. Assoc. Radiol. J. 2021. Vol. 72, No. 2. P. 279–284. DOI: 10.1177/0846537120918834

[69] Chen R, Liang W, Jiang M, et al. Risk Factors of Fatal Outcome in Hospitalized Subjects with Coronavirus Disease 2019 From a Nationwide Analysis in China. Chest. 2020;158(1):97–105. DOI: 10.1016/j.chest.2020.04.010

[70] Chen R., Liang W., Jiang M., et al. Risk Factors of Fatal Outcome in Hospitalized Subjects with Coronavirus Disease 2019 From a Nationwide Analysis in China // Chest. 2020. Vol. 158, No. 1. P. 97–105. DOI: 10.1016/j.chest.2020.04.010

[71] Wang X, Liu W, Zhao J, et al. Clinical characteristics of 80 hospitalized frontline medical workers infected with COVID-19 in Wuhan, China. J Hosp Infect. 2020;105(3):399–403. DOI: 10.1016/j.jhin.2020.04.019

[72] Wang X., Liu W., Zhao J., et al. Clinical characteristics of 80 hospitalized frontline medical workers infected with COVID-19 in Wuhan, China // J. Hosp. Infect. 2020. Vol. 105, No. 3. P. 399–403. DOI: 10.1016/j.jhin.2020.04.019

[73] Du W, Yu J, Wang H, et al. Clinical characteristics of COVID-19 in children compared with adults in Shandong Province, China. Infection. 2020;48(3):445–452. DOI: 10.1007/s15010-020-01427-2

[74] Du W., Yu J., Wang H., et al. Clinical characteristics of COVID-19 in children compared with adults in Shandong Province, China // Infection. 2020. Vol. 48, No. 3. P. 445–452. DOI: 10.1007/s15010-020-01427-2

[75] Ma J, Yin J, Qian Y, Wu Y. Clinical characteristics and prognosis in cancer patients with COVID-19: A single center’s retrospective study. J Infect. 2020;81(2):318–356. DOI: 10.1016/j.jinf.2020.04.006

[76] Ma J., Yin J., Qian Y., Wu Y. Clinical characteristics and prognosis in cancer patients with COVID-19: A single center’s retrospective study // J. Infect. 2020. Vol. 81, No. 2. P. 318–356. DOI: 10.1016/j.jinf.2020.04.006

[77] Chen T, Dai Z, Mo P, et al. Clinical Characteristics and Outcomes of Older Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A Single-Centered, Retrospective Study. J Gerontol A Biol Sci Med Sci. 2020;75(9):1788–1795. DOI: 10.1093/gerona/glaa089

[78] Chen T., Dai Z., Mo P., et al. Clinical Characteristics and Outcomes of Older Patients with Coronavirus Disease 2019 (COVID-19) in Wuhan, China: A Single-Centered, Retrospective Study // J. Gerontol. A Biol. Sci. Med. Sci. 2020. Vol. 75, No. 9. P. 1788–1795. DOI: 10.1093/gerona/glaa089

[79] Zheng F, Tang W, Li H, et al. Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha. Eur Rev Med Pharmacol Sci. 2020;24(6):3404–3410. DOI: 10.26355/eurrev_202003_20711

[80] Zheng F., Tang W., Li H., et al. Clinical characteristics of 161 cases of corona virus disease 2019 (COVID-19) in Changsha // Eur. Rev. Med. Pharmacol. Sci. 2020. Vol. 24, No. 6. P. 3404–3410. DOI: 10.26355/eurrev_202003_20711

[81] Wang L, He W, Yu X, et al. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up. J Infect. 2020;80(6):639–645. DOI: 10.1016/j.jinf.2020.03.019

[82] Wang L., He W., Yu X., et al. Coronavirus disease 2019 in elderly patients: Characteristics and prognostic factors based on 4-week follow-up // J. Infect. 2020. Vol. 80, No. 6. P. 639–645. DOI: 10.1016/j.jinf.2020.03.019

[83] Wang X, Fang J, Zhu Y, et al. Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital. Clin Microbiol Infect. 2020;26(8):1063–1068. DOI: 10.1016/j.cmi.2020.03.032

[84] Wang X., Fang J., Zhu Y., et al. Clinical characteristics of non-critically ill patients with novel coronavirus infection (COVID-19) in a Fangcang Hospital // Clin. Microbiol. Infect. 2020. Vol. 26, No. 8. P. 1063–1068. DOI: 10.1016/j.cmi.2020.03.032

[85] Wan S, Xiang Y, Fang W, et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing. J Med Virol. 2020;92(7):797–806. DOI:1 0.1002/jmv.25783

[86] Wan S., Xiang Y., Fang W., et al. Clinical features and treatment of COVID-19 patients in northeast Chongqing // J. Med. Virol. 2020. Vol. 92, No. 7. P. 797–806. DOI:10.1002/jmv.25783

[87] Wang D, Hu B, Hu C, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China. JAMA. 2020;323(11):1061–1069. DOI: 10.1001/jama.2020.1585

[88] Wang D., Hu B., Hu C., et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China // JAMA. 2020. Vol. 323, No. 11. P. 1061–1069. DOI: 10.1001/jama.2020.1585

[89] Yu X, Sun X, Cui P, et al. Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China. Transboundary and Emerging Diseases. 2020;67(4):1697–1707. DOI: 10.1111/tbed.13604

[90] Yu X., Sun X., Cui P., et al. Epidemiological and clinical characteristics of 333 confirmed cases with coronavirus disease 2019 in Shanghai, China // Transboundary and Emerging Diseases. 2020. Vol. 67, No. 4. P. 1697–1707. DOI: 10.1111/tbed.13604

[91] Alberici F, Delbarba E, Manenti C, et al. A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia. Kidney Int. 2020;97(6):1083–1088. DOI: 10.1016/j.kint.2020.04.002

[92] Alberici F., Delbarba E., Manenti C., et al. A single center observational study of the clinical characteristics and short-term outcome of 20 kidney transplant patients admitted for SARS-CoV2 pneumonia // Kidney Int. 2020. Vol. 97, No. 6. P. 1083–1088. DOI: 10.1016/j.kint.2020.04.002

[93] Yan J, Guo J, Fan C, et al. Coronavirus disease 2019 in pregnant women: a report based on 116 cases. Am J Obstet Gynecol. 2020;223(1):111.e1–111.e14. DOI: 10.1016/j.ajog.2020.04.014

[94] Yan J., Guo J., Fan C., et al. Coronavirus disease 2019 in pregnant women: a report based on 116 cases // Am. J. Obstet. Gynecol. 2020. Vol. 223, No. 1. P. 111.e1–111.e14. DOI: 10.1016/j.ajog.2020.04.014

[95] Pereira MR, Mohan S, Cohen DJ, et al. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter. Am J Transplant. 2020;20(7):1800–1808. DOI: 10.1111/ajt.15941

[96] Pereira M.R., Mohan S., Cohen D.J., et al. COVID-19 in solid organ transplant recipients: Initial report from the US epicenter // Am. J. Transplant. 2020. Vol. 20, No. 7. P. 1800–1808. DOI: 10.1111/ajt.15941

[97] Han C, Duan C, Zhang S, et al. Digestive Symptoms in COVID-19 Patients with Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes. Am J Gastroenterol. 2020;115(6):916–923. DOI: 10.14309/ajg.0000000000000664

[98] Han C., Duan C., Zhang S., et al. Digestive Symptoms in COVID-19 Patients with Mild Disease Severity: Clinical Presentation, Stool Viral RNA Testing, and Outcomes // Am. J. Gastroenterol. 2020. Vol. 115, No. 6. P. 916–923. DOI: 10.14309/ajg.0000000000000664

[99] Feng Y, Ling Y, Bai T, et al. COVID-19 with Different Severities: A Multicenter Study of Clinical Features. Am J Respir Crit Care Med. 2020;201(11):1380–1388. DOI: 10.1164/rccm.202002-0445OC

[100] Feng Y., Ling Y., Bai T., et al. COVID-19 with Different Severities: A Multicenter Study of Clinical Features // Am. J. Respir. Crit. Care Med. 2020. Vol. 201, No. 11. P. 1380–1388. DOI: 10.1164/rccm.202002-0445OC

[101] Cao J, Tu WJ, Cheng W, et al. Clinical Features and Short-term Outcomes of 102 Patients with Coronavirus Disease 2019 in Wuhan, China. Clin Infect Dis. 2020;71(15):748–755. DOI: 10.1093/cid/ciaa243

[102] Cao J., Tu W.J., Cheng W., et al. Clinical Features and Short-term Outcomes of 102 Patients with Coronavirus Disease 2019 in Wuhan, China // Clin. Infect. Dis. 2020. Vol. 71, No. 15. P. 748–755. DOI: 10.1093/cid/ciaa243

[103] Toljan K. Letter to the Editor Regarding the Viewpoint “Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanism”. ACS Chem Neurosci. 2020;11(8):1192–1194. DOI: 10.1021/acschemneuro.0c00174

[104] Toljan K. Letter to the Editor Regarding the Viewpoint “Evidence of the COVID-19 Virus Targeting the CNS: Tissue Distribution, Host–Virus Interaction, and Proposed Neurotropic Mechanism” // ACS Chem. Neurosci. 2020. Vol. 11, No. 8. P. 1192–1194. DOI: 10.1021/acschemneuro.0c00174

[105] Li Y, Bai W, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients. J Med Virol. 2020;92(6):552–555. DOI: 10.1002/jmv.25728

[106] Li Y., Bai W., Hashikawa T. The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients // J. Med. Virol. 2020. Vol. 92, No. 6. P. 552–555. DOI: 10.1002/jmv.25728

[107] Kryukov EV, Shulenin KS, Cherkashin DV, et al. Pathogenesis and clinical manifestations lesions of the cardiovascular system in patients with new coronavirus infection (COVID-19). Saint Petersburg: Veda Print Publisher; 2021. (In Russ.)

[108] Крюков Е.В., Шуленин К.С., Черкашин Д.В., и др. Патогенез и клинические проявления поражения сердечно-сосудистой системы у пациентов с новой коронавирусной инфекцией (COVID-19). СПб.: Веда Принт, 2021. 36 с.

[109] Wu Y, Xu X, Chen Z, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun. 2020;87:18–22. DOI: 10.1016/j.bbi.2020.03.031

[110] Wu Y., Xu X., Chen Z., et al. Nervous system involvement after infection with COVID-19 and other coronaviruses // Brain Behav. Immun. 2020. No. 87. P. 18–22. DOI: 10.1016/j.bbi.2020.03.031

[111] Gusev EI, Martynov MYu, Boyko AN, et al. Novel coronavirus infection (COVID-19) and nervous system involvement: pathogenesis, clinical manifestations, organization of neurological care. Neuroscience and Behavioral Physiology. 2020;120(6):7–16. DOI: 10.17116/jnevro20201200617. (In Russ.)

[112] Гусев Е.И., Мартынов М.Ю., Бойко А.Н., и др. Новая коронавирусная инфекция (COVID-19) и поражение нервной системы: механизмы неврологических расстройств, клинические проявления, организация неврологической помощи // Журнал неврологии и психиатрии им. С.С. Корсакова. 2020. Т. 120, № 6. С. 7–16 DOI: 10.17116/jnevro20201200617

[113] Zairatyants O, Samsonova M, Mikhaleva L, et al. Pathological anatomy of COVID-19: Atlas. Moscow: GBU NIIOZMM DZM Publishing House; 2020. (In Russ.)

[114] Зайратьянц О., Самсонова М., Михалева Л., и др. Патологическая анатомия COVID-19: Атлас. М.: ГБУ НИИОЗММ ДЗМ, 2020.

[115] Gulko E, Oleksk ML, Gomes W, et al. MRI Brain Findings in 126 Patients with COVID-19: Initial Observations from a Descriptive Literature Review. American Journal of Neuroradiology. 2020;41(12):2199–2203. DOI: 10.3174/ajnr.A6805

[116] Gulko E., Oleksk M.L., Gomes W., et al. MRI Brain Findings in 126 Patients with COVID-19: Initial Observations from a Descriptive Li terature Review // American Journal of Neuroradiology. 2020. Vol. 41, No. 12. P. 2199–2203. DOI: 10.3174/ajnr.A6805

[117] Politi LS, Salsano E, Grimaldi M. Magnetic Resonance Imaging Alteration of the Brain in a Patient with Coronavirus Disease 2019 (COVID-19) and Anosmia. JAMA Neurol. 2020;77(8):1028–1029. DOI: 10.1001/jamaneurol.2020.2125

[118] Politi L.S., Salsano E., Grimaldi M. Magnetic Resonance Imaging Alteration of the Brain in a Patient with Coronavirus Disease 2019 (COVID-19) and Anosmia // JAMA Neurol. 2020. Vol. 77, No. 8. P. 1028–1029. DOI: 10.1001/jamaneurol.2020.2125

[119] Román GC, Gracia F, Torres A, et al. Acute Transverse Myelitis (ATM): Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events With the ChAdOx1 nCoV-19 Vaccine (AZD1222). Front Immunol. 2021;12:653–786. DOI: 10.3389/fimmu.2021.653786

[120] Román G.C., Gracia F., Torres A., et al. Acute Transverse Myelitis (ATM): Clinical Review of 43 Patients With COVID-19-Associated ATM and 3 Post-Vaccination ATM Serious Adverse Events with the ChAdOx1 nCoV-19 Vaccine (AZD1222) // Front. Immunol. 2021. No. 12. P. 653786. DOI: 10.3389/fimmu.2021.653786

[121] Zaytsev AA, Chernov SA, Stets VV, et al. Algorithms of the management of patients with a new coronavirus infection COVID-19 in the hospital: guidelines. Consilium Medicum. 2020;22(11):91–97. (In Russ.) DOI: 10.26442/20751753.2020.11.200520

[122] Зайцев А.А., Чернов С.А., Стец В.В., и др. Алгоритмы ведения пациентов с новой коронавирусной инфекцией COVID-19 в стационаре: Методические рекомендации // Consilium Medicum. 2020. Т. 22, № 11. С. 91–97. DOI: 10.26442/20751753.2020.11.200520

RIGHTS & PERMISSIONS

Litvinenko I.V., Odinak M.M., Tsygan N.V., Ryabtsev A.V.